Hematuria Evaluation in Patients with Diabetes

Initial Evaluation and Risk Stratification

The American Urological Association recommends confirming true microscopic hematuria with ≥3 RBCs per high-power field on microscopic examination of at least two of three properly collected clean-catch midstream urine specimens 1, 2.
Dipstick positivity alone has only 65-99% specificity and requires microscopic confirmation 2, 3.
The American College of Radiology suggests that patients with suspected urinary tract infection should have urine culture before antibiotics and repeat urinalysis after treatment to confirm hematuria resolution 5, 3.
The Annals of Internal Medicine states that hematuria should never be attributed to diabetes itself or to anticoagulant/antiplatelet medications, as these may unmask underlying pathology but do not cause hematuria 2, 3, 6.

The Journal of the American College of Radiology recommends examining urinary sediment for dysmorphic RBCs (>80% suggests glomerular origin) and red blood cell casts (pathognomonic for glomerular disease) 3.
Signs suggesting glomerular/renal parenchymal disease include tea-colored or cola-colored urine 5, 3, significant proteinuria (protein-to-creatinine ratio >0.2 g/g or >500-1000 mg/24 hours) 3, 4, and elevated serum creatinine or declining renal function 3, 4.

The American Urological Association recommends using the 2025 AUA/SUFU risk stratification system to determine evaluation intensity 1.
High-risk criteria include >25 RBC/HPF on single urinalysis 1, men ≥60 years old 1, 4, smoking history >30 pack-years 1, 3, and occupational exposure to benzenes or aromatic amines 1, 2, 3.

The Journal of the American College of Radiology suggests that multiphasic CT urography is the preferred imaging modality for upper tract evaluation 5, 3, 4.
Cystoscopy is mandatory for all patients with gross hematuria and for microscopic hematuria patients with intermediate or high-risk factors 1, 3, 4.

The American College of Physicians recommends referring to nephrology if any of the following are present: persistent significant proteinuria, red cell casts or >80% dysmorphic RBCs, elevated creatinine or declining renal function, or hypertension with hematuria and proteinuria 3.
Additional glomerular workup may include complement levels, antinuclear antibody (ANA) and ANCA testing, renal ultrasound, and consideration of renal biopsy 3.

The American Urological Association recommends repeating urinalysis, voided urine cytology, and blood pressure measurement at 6, 12, 24, and 36 months if complete workup is negative but hematuria persists 3, 4.
Immediate re-evaluation is warranted if gross hematuria develops, significant increase in degree of microscopic hematuria occurs, new urologic symptoms appear, or development of hypertension, proteinuria, or evidence of glomerular bleeding is noted 3, 4.